Formerly titled: Ethnoracial issues and Psychopharmacology. In the US, psychopharmacology has been in existence for approximately 70 years since the FDA approval of Thorazine (1952). Much of the research focus has been on group differences associated with age and gender. Surprisingly, little research has focused on different ethnoracial groups. This presentation will look at differences in how medications are absorbed, distributed and metabolized (known as pharmacokinetics) across groups. In addition, there are differences in how ethnoracial groups view the value of psychotropic medication including medication adherence, another area to be discussed within this workshop.
At the conclusion of this webinar, participants will be able to:
- Summarize the difficulties associated with ethnoracial research in pharmacology
- List several differences between groups based on pharmacokinetics as applied to different psychotropic medications
- Summarize the impact of the Tuskegee research project on reluctance by ethnoracial groups to take part in research studies and to take medications in general
- List at least three reasons why people may not want to take medication
9:30 am Welcome/Introduction
9:40 am Challenges and History
10:00 am Definitions and Language Overview
10:15 am Biology
- Liver Function
- Genetics
- Metabolizer types
- Pharmacokinetics (ADME)
- Pharmacodynamics
11:00 am Specific Medication Examples
- The Tuskegee Research Project
12:00 pm Social Bias
12:20 pm Conclusion/Q&A